Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-08-09
1985-06-04
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549495, A01K 3134, C07D30752
Patent
active
045214310
ABSTRACT:
A novel crystal form of ranitidine (N-[2-[[[5-(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl-N'-methyl-2- nitro-1,1-ethenediamine) hydrochloride, designated Form 2, and having favorable filtration and drying characteristics, is characterized by its infra-red spectrum and/or by its x-ray powder diffraction patterns.
REFERENCES:
patent: 4128658 (1978-12-01), Price et al.
patent: 4279819 (1981-07-01), Price et al.
Glaxo Group Limited
Raymond Richard L.
LandOfFree
Aminoalkyl furan derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkyl furan derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkyl furan derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-828421